RANKINGS

Lowest EV/EBITDA — Healthcare

Enterprise Value to EBITDA. Lower ratios may indicate undervaluation.

69 companies with EV/EBITDA data.

Ranked by EV/EBITDA(69)

#	Ticker	Name	Industry	Market Cap	EV/EBITDA
1	GURE	GULF RESOURCES, INC. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$6M	0.3
2	CF	CF INDUSTRIES HOLDINGS, INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$17.3B	4.4
3	VHI	VALHI, INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$405M	5.3
4	ANIP	ANI PHARMACEUTICALS, INC TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$1.7B	6.9
5	CBT	Cabot Corporation TTM · 2026-06-30 Analysis WACC DCF	Other	$3.8B	7.0
6	LXU	LSB Industries, Inc. TTM · 2026-06-30 Analysis WACC DCF	Other	$706M	7.7
7	BTMD	biote Corp. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$33M	7.7
8	PAHC	Phibro Animal Health Corporation FY · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$1.5B	8.9
9	BMY	BRISTOL-MYERS SQUIBB COMPANY TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$117.6B	9.0
10	EMN	EASTMAN CHEMICAL CO TTM · 2026-06-30 Analysis WACC DCF	Other	$7.1B	9.1
11	SCL	STEPAN COMPANY FY · 2025-12-31 Analysis WACC DCF	Other	$1.4B	9.4
12	ZTS	Zoetis Inc. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$31.3B	9.7
13	RIGL	RIGEL PHARMACEUTICALS, INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$912M	9.9
14	CLX	CLOROX CO /DE/ TTM · 2026-03-31 Analysis WACC DCF	Other	$10.2B	10.1
15	BHC	Bausch Health Companies Inc. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$2.2B	10.3
16	ALTO	ALTO INGREDIENTS, INC. FY · 2025-12-31 Analysis WACC DCF	Other	$284M	10.3
17	MOS	MOSAIC CO TTM · 2026-06-30 Analysis WACC DCF	Other	$6.0B	10.6
18	SMG	Scotts Miracle-Gro Co TTM · 2026-06-27 Analysis WACC DCF	Other	$2.9B	10.8
19	RPM	RPM International Inc. TTM · 2026-08-31 Analysis WACC DCF	Other	$12.4B	11.3
20	OLN	Olin Corporation TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$1.7B	11.5
21	VTRS	VIATRIS INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$20.1B	12.0
22	LYB	LYONDELLBASELL INDUSTRIES N.V. TTM · 2026-06-30 Analysis WACC DCF	Other	$19.2B	12.2
23	KVUE	Kenvue Inc. TTM · 2026-06-28 Analysis WACC DCF	Other	$34.2B	12.6
24	IPAR	INTERPARFUMS, INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$3.6B	12.6
25	AVNT	AVIENT CORPORATION FY · 2025-12-31 Analysis WACC DCF	Other	$3.6B	12.9
26	ALB	ALBEMARLE CORPORATION TTM · 2026-06-30 Analysis WACC DCF	Other	$11.6B	13.3
27	PPG	PPG INDUSTRIES INC TTM · 2026-03-31 Analysis WACC DCF	Other	$23.1B	13.5
28	COTY	COTY INC. FY · 2026-06-30 Analysis WACC DCF	Other	$2.6B	13.7
29	TEVA	TEVA PHARMACEUTICAL INDUSTRIES LIMITED FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$48.0B	15.5
30	LXFR	LUXFER HOLDINGS PLC TTM · 2026-03-29 Analysis WACC DCF	Other	$466M	15.8
31	IFF	INTERNATIONAL FLAVORS & FRAGRANCES INC TTM · 2026-06-30 Analysis WACC DCF	Other	$21.7B	15.9
32	PFE	PFIZER INC TTM · 2026-06-28 Analysis WACC DCF	Pharmaceuticals	$161.9B	16.1
33	PG	PROCTER & GAMBLE CO FY · 2026-06-30 Analysis WACC DCF	Other	$355.8B	16.6
34	LNTH	LANTHEUS HOLDINGS, INC. TTM · 2026-06-30 Analysis WACC DCF	Biotechnology	$6.5B	16.7
35	AMGN	Amgen Inc. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$225.8B	16.7
36	SOLS	Solstice Advanced Materials Inc. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$9.6B	17.2
37	MTEX	MANNATECH INC FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$15M	17.4
38	OPK	OPKO Health, Inc. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$1.0B	17.6
39	REGN	REGENERON PHARMACEUTICALS, INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$78.5B	17.9
40	JAZZ	Jazz Pharmaceuticals plc TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$14.1B	18.0
41	LIN	Linde plc TTM · 2026-06-30 Analysis WACC DCF	Other	$224.7B	18.2
42	JNJ	Johnson & Johnson FY · 2025-12-28 Analysis WACC DCF	Pharmaceuticals	$635.6B	19.4
43	CHD	CHURCH & DWIGHT CO., INC. FY · 2025-12-31 Analysis WACC DCF	Other	$23.7B	19.4
44	ICCC	ImmuCell Corporation FY · 2025-12-31 Analysis WACC DCF	Biotechnology	$87M	19.5
45	CL	COLGATE-PALMOLIVE COMPANY TTM · 2026-06-30 Analysis WACC DCF	Other	$71.7B	20.8
46	SXT	Sensient Technologies Corp TTM · 2026-06-30 Analysis WACC DCF	Other	$5.5B	20.8
47	HXL	Hexcel Corporation TTM · 2026-06-30 Analysis WACC DCF	Other	$6.4B	20.9
48	WDFC	WD-40 COMPANY TTM · 2026-05-31 Analysis WACC DCF	Other	$2.7B	21.6
49	ABT	ABBOTT LABORATORIES TTM · 2026-03-31 Analysis WACC DCF	Pharmaceuticals	$176.2B	22.2
50	HALO	HALOZYME THERAPEUTICS, INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$12.6B	23.8
51	FTK	FLOTEK INDUSTRIES INC/CN TTM · 2026-06-30 Analysis WACC DCF	Other	$929M	24.3
52	ECL	ECOLAB INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$79.7B	24.6
53	EL	Estee Lauder Companies Inc FY · 2026-06-30 Analysis WACC DCF	Other	$36.2B	25.1
54	IDXX	IDEXX LABORATORIES INC /DE TTM · 2026-06-30 Analysis WACC DCF	Biotechnology	$41.3B	25.8
55	PTCT	PTC Therapeutics, Inc. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$5.3B	26.5
56	DD	DUPONT DE NEMOURS, INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$17.5B	28.1
57	TECH	BIO-TECHNE Corp FY · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$11.4B	32.4
58	ABBV	AbbVie Inc. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$496.8B	34.9
59	MRK	Merck & Co., Inc. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$358.9B	37.2
60	LLY	ELI LILLY AND COMPANY FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$1.1T	38.4
61	MNKD	MannKind Corporation TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$1.0B	42.3
62	BMRN	BIOMARIN PHARMACEUTICAL INC TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$10.7B	46.4
63	LGND	LIGAND PHARMACEUTICALS INCORPORATED TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$6.2B	49.5
64	KRO	KRONOS WORLDWIDE, INC. FY · 2025-12-31 Analysis WACC DCF	Other	$857M	57.8
65	TGTX	TG THERAPEUTICS, INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$8.5B	63.9
66	FSI	FLEXIBLE SOLUTIONS INTERNATIONAL INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$78M	65.6
67	RGEN	REPLIGEN CORP TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$11.0B	76.0
68	APD	AIR PRODUCTS AND CHEMICALS, INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$63.2B	84.1
69	DOW	DOW INC. FY · 2025-12-31 Analysis WACC DCF	Other	$20.3B	85.8